Efferon Jsc
Clinical trials sponsored by Efferon Jsc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to clean blood of burn toxins Results expected Dec 2026 (estimated)
- Blood filter may calm the deadly inflammation of cardiogenic shock Results expected Apr 2027 (estimated)
- Blood filter device aims to tame severe IBD flares Results expected Sep 2027 (estimated)
-
New blood filter aims to prevent organ failure in severe burn victims
Disease control Not yet recruitingThis study tests a blood-filtering device called Efferon LPS in 50 people with severe burns. The goal is to see if it can reduce dangerous inflammation and prevent organ failure. Participants will either receive standard care or standard care plus the blood filter. The study focu…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blood filter device aims to tame severe IBD flares
Disease control Not yet recruitingThis study tests a blood-filtering device called Efferon LPS in 40 adults with Crohn's disease or ulcerative colitis during a flare-up. The device is designed to remove harmful substances from the blood to reduce inflammation. Participants will either receive standard care alone …
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC